DK2809810T3 - System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer - Google Patents
System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer Download PDFInfo
- Publication number
- DK2809810T3 DK2809810T3 DK13733697.0T DK13733697T DK2809810T3 DK 2809810 T3 DK2809810 T3 DK 2809810T3 DK 13733697 T DK13733697 T DK 13733697T DK 2809810 T3 DK2809810 T3 DK 2809810T3
- Authority
- DK
- Denmark
- Prior art keywords
- perferral
- blood
- detecting
- lung cancer
- modified rnas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261584097P | 2012-01-06 | 2012-01-06 | |
PCT/US2013/020383 WO2013103889A1 (en) | 2012-01-06 | 2013-01-04 | System and method of detecting rnas altered by cancer in peripheral blood |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2809810T3 true DK2809810T3 (da) | 2020-02-03 |
Family
ID=48745455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13733697.0T DK2809810T3 (da) | 2012-01-06 | 2013-01-04 | System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer |
Country Status (12)
Country | Link |
---|---|
US (2) | US9422592B2 (da) |
EP (1) | EP2809810B1 (da) |
JP (2) | JP2015503356A (da) |
AU (1) | AU2013207385B2 (da) |
CA (1) | CA2860338C (da) |
DK (1) | DK2809810T3 (da) |
ES (1) | ES2769795T3 (da) |
HU (1) | HUE047739T2 (da) |
IL (1) | IL233163B (da) |
PL (1) | PL2809810T3 (da) |
PT (1) | PT2809810T (da) |
WO (1) | WO2013103889A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3126529B1 (en) | 2014-03-31 | 2020-05-27 | Mayo Foundation for Medical Education and Research | Detecting colorectal neoplasm |
CA2965528A1 (en) | 2014-11-14 | 2016-05-19 | Liquid Genomics, Inc. | Use of circulating cell-free rna for diagnosis and/or monitoring cancer |
CN108350485A (zh) | 2015-10-30 | 2018-07-31 | 精密科学发展有限责任公司 | 血浆dna的多重扩增检测测定以及分离和检测 |
AU2018266162A1 (en) * | 2017-05-10 | 2020-01-02 | Nantomics, Llc | Circulating RNA for detection, prediction, and monitoring of cancer |
WO2018226971A1 (en) * | 2017-06-07 | 2018-12-13 | Cedars-Sinai Medical Center | Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery |
SG11202002711WA (en) | 2017-10-12 | 2020-04-29 | Nantomics Llc | Cancer score for assessment and response prediction from biological fluids |
AU2018365883A1 (en) | 2017-11-07 | 2020-05-14 | Nanthealth Labs, Inc. | Targeted cell free nucleic acid analysis |
AU2019403269A1 (en) * | 2018-12-18 | 2021-06-17 | Grail, Llc | Methods for detecting disease using analysis of RNA |
US11345967B2 (en) | 2019-05-23 | 2022-05-31 | Paradigm Diagnostics | Tissue preparation using nuclease |
AU2020336115A1 (en) * | 2019-08-27 | 2022-04-14 | Exact Sciences Corporation | Characterizing methylated DNA, RNA, and proteins in subjects suspected of having lung neoplasia |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100236506B1 (ko) | 1990-11-29 | 2000-01-15 | 퍼킨-엘머시터스인스트루먼츠 | 폴리머라제 연쇄 반응 수행 장치 |
CA2218875C (en) | 1991-07-23 | 2000-11-07 | The Research Foundation Of State University Of New York | Improvements in the in situ pcr |
KR0171154B1 (ko) | 1995-04-29 | 1999-03-20 | 배순훈 | 특징점 기반 움직임 추정을 이용하여 비디오 신호를 부호화하는 방법 및 장치 |
US6040139A (en) | 1995-09-19 | 2000-03-21 | Bova; G. Steven | Laser cell purification system |
US6329179B1 (en) | 1996-03-26 | 2001-12-11 | Oncomedx, Inc. | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
US6759217B2 (en) | 1996-03-26 | 2004-07-06 | Oncomedx, Inc. | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
US7785842B2 (en) | 1996-03-26 | 2010-08-31 | Oncomedx, Inc. | Comparative analysis of extracellular RNA species |
US8043835B1 (en) | 1996-03-26 | 2011-10-25 | Oncomedx, Inc. | Methods for detecting and monitoring cancer using extracellular RNA |
US6100051A (en) | 1997-06-27 | 2000-08-08 | The United States Of America As Represented By The Department Of Health And Human Services | Method utilizing convex geometry for laser capture microdissection |
US8163524B2 (en) | 1998-09-22 | 2012-04-24 | Oncomedx, Inc. | Comparative analysis of extracellular RNA species |
US7767422B2 (en) | 1998-09-22 | 2010-08-03 | Oncomedx, Inc. | Detection of 5T4 RNA in plasma and serum |
US20040085443A1 (en) | 2000-12-13 | 2004-05-06 | Kallioniemi Olli P | Method and system for processing regions of interest for objects comprising biological material |
WO2003044215A2 (en) | 2001-11-20 | 2003-05-30 | Oncomedx, Inc. | Methods for evaluating drug-resistance gene expression in the cancer patient |
WO2003074069A2 (en) * | 2002-03-07 | 2003-09-12 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) |
WO2003102185A2 (en) | 2002-05-30 | 2003-12-11 | Telogene Inc. | Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
US7955846B2 (en) | 2004-05-17 | 2011-06-07 | The General Hospital Corporation | Compositions comprising female germline stem cells and methods of use thereof |
US20060051736A1 (en) | 2004-08-19 | 2006-03-09 | Applied Imaging Corp. | Paraffin-control marker |
EP2230315A1 (en) | 2005-02-01 | 2010-09-22 | AB Advanced Genetic Analysis Corporation | Nucleic acid sequencing by performing successive cycles of duplex extension |
US7405056B2 (en) | 2005-03-02 | 2008-07-29 | Edward Lam | Tissue punch and tissue sample labeling methods and devices for microarray preparation, archiving and documentation |
CA2633754C (en) | 2006-01-05 | 2013-06-18 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis and treatment of solid cancers |
US8252538B2 (en) | 2006-11-01 | 2012-08-28 | The Ohio State University | MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma |
US8189882B2 (en) | 2008-01-30 | 2012-05-29 | Clarient, Inc. | Automated laser capture microdissection |
US8880351B2 (en) | 2008-03-25 | 2014-11-04 | General Electric Company | Method and apparatus for analysis of tissue microarrays |
EP3181705A1 (en) | 2008-11-12 | 2017-06-21 | Caris Life Sciences Switzerland Holdings GmbH | Methods and systems of using exosomes for determining phenotypes |
US8765383B2 (en) * | 2009-04-07 | 2014-07-01 | Genomic Health, Inc. | Methods of predicting cancer risk using gene expression in premalignant tissue |
WO2010123124A1 (ja) * | 2009-04-24 | 2010-10-28 | 国立大学法人九州大学 | 固形がんの再発および予後因子、およびその臨床利用 |
-
2013
- 2013-01-04 PL PL13733697T patent/PL2809810T3/pl unknown
- 2013-01-04 PT PT137336970T patent/PT2809810T/pt unknown
- 2013-01-04 CA CA2860338A patent/CA2860338C/en active Active
- 2013-01-04 ES ES13733697T patent/ES2769795T3/es active Active
- 2013-01-04 US US13/734,735 patent/US9422592B2/en active Active
- 2013-01-04 AU AU2013207385A patent/AU2013207385B2/en active Active
- 2013-01-04 WO PCT/US2013/020383 patent/WO2013103889A1/en active Application Filing
- 2013-01-04 HU HUE13733697A patent/HUE047739T2/hu unknown
- 2013-01-04 EP EP13733697.0A patent/EP2809810B1/en active Active
- 2013-01-04 JP JP2014551375A patent/JP2015503356A/ja active Pending
- 2013-01-04 DK DK13733697.0T patent/DK2809810T3/da active
-
2014
- 2014-06-16 IL IL233163A patent/IL233163B/en active IP Right Grant
-
2016
- 2016-07-28 US US15/222,828 patent/US20160333424A1/en not_active Abandoned
-
2019
- 2019-03-13 JP JP2019045627A patent/JP2019162102A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2013207385B2 (en) | 2018-09-13 |
US20130196332A1 (en) | 2013-08-01 |
EP2809810B1 (en) | 2019-11-13 |
CA2860338C (en) | 2022-08-02 |
US20160333424A1 (en) | 2016-11-17 |
HUE047739T2 (hu) | 2020-05-28 |
PT2809810T (pt) | 2020-02-14 |
EP2809810A1 (en) | 2014-12-10 |
JP2015503356A (ja) | 2015-02-02 |
US9422592B2 (en) | 2016-08-23 |
IL233163A0 (en) | 2014-07-31 |
CA2860338A1 (en) | 2013-07-11 |
WO2013103889A1 (en) | 2013-07-11 |
AU2013207385A1 (en) | 2014-07-10 |
PL2809810T3 (pl) | 2020-07-27 |
EP2809810A4 (en) | 2015-12-02 |
IL233163B (en) | 2019-02-28 |
ES2769795T3 (es) | 2020-06-29 |
JP2019162102A (ja) | 2019-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2809810T3 (da) | System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer | |
BR112013028966A2 (pt) | sistema fotobiorreator de calha em v e método de uso | |
DK2914743T3 (da) | Udvinding, detektering og kvantificering af lille rna | |
DK2852680T3 (da) | Fremgangsmåder og processer til ikke-invasiv evaluering af genetiske variationer | |
DK2681227T3 (da) | Phosphoramidatderivater af 5-fluor-2'-deoxyuridin til anvendelse i behandlingen af cancer | |
BRPI1008909A2 (pt) | métodos e sistema de tratamento de veia | |
EP2779907A4 (en) | SYSTEM AND METHOD FOR MEDICAL MEASUREMENT | |
DK3358011T3 (da) | Peptid til inducering af regenerering af væv og anvendelse deraf | |
BRPI1007758A2 (pt) | sistema e método de medição de mudanças de volume arterial de um segmento de membro | |
BR112013021971A2 (pt) | sistema médico e método. | |
BR112013021984A2 (pt) | métodos e sistema de tratamento de poço | |
DK2743670T3 (da) | Fejldetekteringssystem og tilhørende metode | |
BR112013022764A2 (pt) | sistema médico e método | |
DK3035849T3 (da) | Lægemiddeleluering til beskyttelse in vivo af biosensor-analysander | |
GB201400630D0 (en) | System and method to measure or generate an electriacl field downhole | |
DK2815769T3 (da) | Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet | |
DK2632954T4 (da) | Midler og fremgangsmåder til behandling af dlbcl | |
DK2663336T3 (da) | Fremgangsmåder og reagenser til effektiv og targeteret afgivelse af terapeutiske molekyler til CXCR4-celler | |
BR112013027414A2 (pt) | bolão de cateter e método para revestimento do mesmo | |
BR112013003528A2 (pt) | ''solução para extrair rna e métodos para extrair rna'' | |
DE102011085408A8 (de) | Meßwandler sowie damit gebildetes Meßsystem | |
DK2719005T3 (da) | Fremgangsmåde og system til genindvinding af bestanddele af batterier | |
CL2013002863A1 (es) | Sistema y metodos de transaccion financiera. | |
DK2800575T3 (da) | Behandling af subarachnoidalblødning og iskæmi | |
DK2834643T3 (da) | Fremgangsmåde til behandling af blod, blodprodukter og organer |